Martin Schecklmann Selected Research

Martin Schecklmann Research Topics

45	Tinnitus 07/2023 - 01/2011
6	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2014 - 12/2008
5	Schizophrenia (Dementia Praecox) 09/2018 - 08/2011
3	Epilepsy (Aura) 01/2017 - 01/2012
3	Autism Spectrum Disorder 09/2014 - 09/2011
2	Depressive Disorder (Melancholia) 02/2022 - 01/2019
2	Psychotic Disorders (Schizoaffective Disorder) 10/2020 - 06/2014
2	Mood Disorders (Mood Disorder) 09/2014 - 01/2012
1	Major Depressive Disorder (Major Depressive Disorders) 01/2024
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2023
1	Idiopathic Hypersomnia 01/2023
1	Sleepiness 01/2023
1	Sleep Wake Disorders 01/2023
1	Narcolepsy 01/2023
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2023
1	Bipolar Disorder (Manic Depressive Psychosis) 02/2022
1	Hearing Loss (Hearing Impairment) 01/2021
1	Pain (Aches) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Aphasia (Dysphasia) 01/2017
1	Consciousness Disorders 01/2017
1	Fibromyalgia (Fibrositis) 01/2017
1	Movement Disorders (Movement Disorder) 01/2017
1	Multiple Sclerosis 01/2017
1	Neuralgia (Stump Neuralgia) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Stroke (Strokes) 01/2017
1	Mental Disorders (Mental Disorder) 01/2013
1	Dementia (Dementias) 07/2012
1	Hypothermia 07/2012
1	Sleep Deprivation 04/2012

6	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2016
4	Dopamine (Intropin)FDA LinkGeneric 11/2011 - 12/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2011
3	Antipsychotic Agents (Antipsychotics)IBA 06/2014 - 07/2012
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2014
2	Therapeutic UsesIBA 01/2017 - 01/2012
2	Messenger RNA (mRNA)IBA 09/2014 - 09/2011
2	Quetiapine Fumarate (Seroquel)FDA Link 06/2014 - 06/2014
2	Methylphenidate (Ritalin)FDA LinkGeneric 11/2011 - 12/2008
1	TESIBA 01/2023
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2019
1	E 10 (E-10)IBA 01/2019
1	PlacebosIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	Oxytocin (Pitocin)FDA LinkGeneric 09/2014
1	Nerve Growth Factors (Neurotrophins)IBA 09/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2014
1	N 30IBA 06/2014
1	BenperidolIBA 07/2012
1	Olanzapine (Zyprexa)FDA Link 07/2012
1	Antidepressive Agents (Antidepressants)IBA 04/2012
1	cyclobenzaprine FDA LinkGeneric 01/2012
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 08/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2011
1	Glutamic Acid (Glutamate)FDA Link 08/2011

30	Transcranial Magnetic Stimulation 01/2023 - 01/2011
8	Therapeutics 07/2023 - 07/2012
6	Transcranial Direct Current Stimulation 01/2024 - 02/2012
4	Aftercare (After-Treatment) 10/2020 - 01/2016
3	Hearing Aids (Hearing Aid) 07/2023 - 01/2021
2	Duration of Therapy 01/2021 - 01/2019
2	Electrodes (Electrode) 01/2015 - 02/2012
2	Vagus Nerve Stimulation 09/2014 - 01/2012
1	Deep Brain Stimulation 01/2023
1	Combined Modality Therapy 01/2018
1	Relaxation Therapy (Relaxation Technique) 10/2016
1	Drug Therapy (Chemotherapy) 01/2012